Defense Earnings Week Opens With Three Raised Forecasts and Two Record Backlogs

RTX, Northrop Grumman and GE Aerospace all raised 2026 guidance after reporting third-quarter results; RTX cited a record $340 billion backlog, including $164 billion in defense, while Northrop reported $109.6 billion in backlog. RTX sales rose 11% to $25.0 billion, Northrop sales rose 7% to $11.1 billion, and GE adjusted revenue rose 18% to $13.3 billion. Shares moved in different directions: Northrop gained 4.57%, RTX rose 0.64%, and GE fell 3.67%. The article also cites a $1.5 trillion FY2027 U.S. defense budget request and NATO allies’ 5%-of-GDP defense investment commitment by 2035, while noting the request is not an appropriation and current funding restrictions remain.

Analysis

The key distinction is backlog quality and conversion, not the headline guidance raises. A continuing resolution limits the near-term ability to accelerate production, so a large order book may extend revenue visibility without translating quickly into incremental deliveries or cash. The next proof points are appropriations and execution: production rates, delivery schedules, and cash conversion. Multi-year awards that remain undefinitized add contract-pricing and timing uncertainty.

Near term, Lockheed Martin’s report is the cleanest catalyst; L3Harris follows next week. Watch for funded orders, delivery cadence, margins, and free-cash-flow conversion rather than another backlog record. A December 11 funding deadline creates a policy catalyst, but a large budget request is not enacted spending. Over 6–18 months, capacity constraints could shift value toward suppliers able to deliver components and skilled labor, while delaying prime-contractor revenue recognition.

GE Aerospace’s weaker share reaction despite raised guidance cautions against treating sector results as a uniform re-rating: commercial-services strength and defense exposure have different drivers. The contrarian risk is that investors capitalize long-dated backlog as near-term earnings while underweighting funding and conversion friction. Conversely, a timely appropriation plus measurable production increases could make current backlog concerns too conservative.

Key Decisions for Investors

• Keep broad defense exposure selective rather than buying the sector on backlog headlines. For the next 1–3 months, monitor Lockheed Martin’s October 22 report and L3Harris’s October 29 report for funded awards, delivery rates, segment margins, and cash flow; treat further backlog growth without conversion evidence as a weak signal.
• Consider a modest relative-value position: long Northrop Grumman versus a broad aerospace-and-defense basket, with position sizing constrained by valuation and execution data not provided here. The thesis is relative operating momentum, not an assumption that its backlog converts faster; reduce or exit if guidance, book-to-bill, or cash conversion deteriorates.
• Avoid chasing RTX solely on its raised outlook. Verify how much of earnings growth reflects recurring operations versus the stated IEEPA cost recovery, and track contract definitization and production cadence. A reversal in guidance or evidence of delayed deliveries would falsify the near-term positive setup.
• Use December 11 as a policy checkpoint, not a guaranteed catalyst: a continuing resolution or delayed appropriations would reinforce the risk that production acceleration slips. A funded appropriation accompanied by company-confirmed rate increases would weaken that downside case.